X-153536398-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001001344.3(ATP2B3):c.151G>A(p.Glu51Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000332 in 1,204,751 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001001344.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000882 AC: 1AN: 113394Hom.: 0 Cov.: 25 AF XY: 0.00 AC XY: 0AN XY: 35522
GnomAD4 exome AF: 0.00000275 AC: 3AN: 1091357Hom.: 0 Cov.: 31 AF XY: 0.00000279 AC XY: 1AN XY: 358513
GnomAD4 genome AF: 0.00000882 AC: 1AN: 113394Hom.: 0 Cov.: 25 AF XY: 0.00 AC XY: 0AN XY: 35522
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.151G>A (p.E51K) alteration is located in exon 1 (coding exon 1) of the ATP2B3 gene. This alteration results from a G to A substitution at nucleotide position 151, causing the glutamic acid (E) at amino acid position 51 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at